The Clinical Research Support (CRS) Medical Director will work in partnership with the administrative Director of CRS to set the strategic direction of the Cancer Consortium’s clinical research infrastructure. The incumbent will serve as the primary faculty representative on clinical research-related initiatives across Fred Hutch, the University of Washington (UW), Seattle Children’s and the Seattle Cancer Care Alliance (SCCA) and will provide direction to the Consortium’s clinical trials office, CRS. CRS currently provides support for over 400 clinical research staff and faculty, and over 600 active clinical trials and 1,500 clinical research studies. CRS is responsible for ensuring the efficient review, approval, and implementation of cancer clinical research throughout the Cancer Consortium. CRS ensures high quality, regulatory compliant clinical research through quality control functions including trial monitoring and auditing, training, and policy development.
The incumbent will dedicate 40% effort to the CRS Medical Director position; the remaining effort will be allocated to clinic service and academic pursuits including teaching and research. The CRS Medical Director reports to the Cancer Consortium Director or Deputy Director as designated.